The enhancement of intestinal barrier function prevents the influx of endotoxins into the liver with the blood, thereby inhibiting the TLR4/NF-κB pathway and mitigating lipid metabolism disorders. The gene discussed is NFKB1; the disease is Disorder of lipid metabolism.